Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04175678 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date changed from estimate of Mar 3, 2025 to Sep 3, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Mar 3, 2025 to Jun 30, 2026
    • Site details revised
    v11
  2. Notable Primary endpoints: 3 to 1
    • Secondary endpoints: 18 to 5
    • Collaborator revised
    v10
  3. Notable Primary completion date: Dec 31, 2023 to Mar 3, 2025
    • Study completion date: Mar 31, 2024 to Mar 3, 2025
    • Start date: Mar 1, 2020 to Feb 21, 2020
    v9
  4. Notable Primary endpoints revised (3)
    • Secondary endpoints revised (18)
    v8
  5. Notable Primary completion date: Mar 3, 2025 to Dec 31, 2023v7 Show 7 more changesShow less
    • Primary endpoints: 1 to 3
    • Study completion date: Mar 3, 2025 to Mar 31, 2024
    • Start date: Feb 21, 2020 to Mar 1, 2020
    • Interventions: Diet (Other), Exercise (Other) to Diet (Other), Exercise (Other), Standard care (Other)
    • Secondary endpoints expanded, about 162 words
    • Study description expanded, about 108 words
    • Eligibility criteria expanded, about 3 words
Show 5 earlier versionsHide 5 earlier versions
  1. Minor 2 versions Re-verified since Jan 26, 2021, no change to tracked fieldsv5-v6
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v4
  3. Notable Start date: Jan 3, 2020 to Feb 21, 2020v3
  4. Minor Study description expanded, about 4 wordsv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a rigorous, controlled clinical trial designed to show that diet, exercise training, and their combination in overweight, inactive men will alter epigenetic programming to create a "healthy" sperm epigenome. Our central hypotheses are: i) overweight and inactive lifestyle results in epimutations in the sperm epigenome relative to the normal epigenetic programming in lean and active men and ii) diet and exercise modulation leads to reversal of these epimutations resulting in both a healthier "phenotype" and "epigenotype" which may persist after stopping the interventions. The study is divided into three parts: 1. We will recruit 20 healthy, active men and 20 obese and inactive Hispanic men between 18 and 40 years to determine the differences in sperm epigenome (DNA methylation, histone modifications and non-coding RNAs) in a cross-sectional study in obese inactive vs. healthy active Hispanic men. Only Hispanic men will be studied because of the high prevalence of obesity and inactivity in Hispanic younger men and to reduce the genetic variability influencing the epigenome. 2. 80 obese and inactive men will be randomized to 4 groups of 20 men: 1) No intervention (control); 2) Low fat, low caloric diet; 3) Supervised, periodized endurance and resistance training without modification of diet; and 4) Both exercise and diet modification to characterize the plasticity of the sperm epigenome in response to 12-week diet and/or exercise training interventions in obese and inactive Hispanic men. Sperm epimutations will be compared before and after intervention within each group and between groups. 3. The sperm epigenome studies in 80 men randomized to no intervention or diet and/or exercise training will be repeated at 12 and 36 weeks after cessation of interventions to Identify the persistent effects of diet and exercise training on the sperm epigenome after stopping the interventions.
Trial Details
NCT Number NCT04175678
Lead Sponsor Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions
(from sponsor)
Healthy Lifestyle, Obese, Men
Related terms Motor Activity, Multiple Endocrine Neoplasia Type 1, Obesity
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov